Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 28
State Judge Vacates Jury Defense Verdict in N.J. Vioxx Case
Arthritis Drugs - Issue: 27
Judge Denies Merck Motion for Judgment During Barnett Trial
Merck Seeks to Stay Plaintiff's 'Identical,' Second-Filed Vioxx Lawsuit
Federal Vioxx MDL Plaintiff Moves to Compel Further Document Production
Learned Intermediary Doctrine Not Basis for Removal, Judge Says
Plaintiffs: Preemption Standards Not Applicable to Bextra, Celebrex Claims
Vioxx Parties Submit Schedule, Withdraw 2 Cases from 2nd Calif. Trial
Judge Dismisses Vioxx Action Seeking Default Judgment, Treble Damages
